We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Paris Hosts Journees Internationales de Biologie

By Labmedica staff writers
Posted on 06 Dec 2004
Record-breaking attendance was announced for the 49th Journees Internationales de Biologie (JIB), held in Paris (France) in November 2004. More...
More then 8,000 visitors attended, and 145 companies exhibited their latest technologies. The event was organized by the Syndicat des Biologistes (SDB) for professionals in the field of medical biology in Europe. Attendees included clinical biologists, biomedical engineers, laboratory technicians, hospital physicians, and all those working in the field of in vitro diagnostics.

More than 1,100 participants attended the scientific conferences. This year, topics linked to day-to-day laboratory practice aroused strong interest. The first training course aimed at secretaries from private medical laboratories was filled to capacity. The objective of this first session was to respond to changes in a medical secretary's job by exploring the technical and legal aspects concerning patients' rights, medical confidentiality, and the releasing of medical test results. Also, humanitarian aid projects undertaken by biologists and diagnostics manufacturers who intervene in emerging countries and contribute to the evolution of medical biology and sustainable development were highlighted.

In 2005 the JIB will celebrate its 50th anniversary, with the meeting again held in Paris, November 3-5. An appealing scientific program is planned, including a session on the prospects of human therapeutic cloning and the therapeutic hope linked to stem cells.




Related Links:
JIB

New
Gold Member
Automated Clinical Chemistry Analyzer
Envoy 500+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Repetitive Pipette
VWR® Stepper Pro
New
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.